Wells Fargo & Company MN increased its position in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 158.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 216,049 shares of the construction company's stock after buying an additional 132,489 shares during the quarter. Wells Fargo & Company MN owned 0.26% of Aspen Aerogels worth $2,567,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Prescott Group Capital Management L.L.C. purchased a new stake in Aspen Aerogels during the 4th quarter valued at about $5,126,000. Trexquant Investment LP bought a new stake in Aspen Aerogels in the fourth quarter valued at approximately $4,760,000. Telemark Asset Management LLC boosted its stake in shares of Aspen Aerogels by 26.8% during the fourth quarter. Telemark Asset Management LLC now owns 1,892,424 shares of the construction company's stock valued at $22,482,000 after purchasing an additional 400,000 shares during the period. Lord Abbett & CO. LLC bought a new position in shares of Aspen Aerogels in the third quarter worth approximately $10,126,000. Finally, Raymond James Financial Inc. purchased a new position in shares of Aspen Aerogels in the fourth quarter worth $2,909,000. Hedge funds and other institutional investors own 97.64% of the company's stock.
Analysts Set New Price Targets
Several brokerages have weighed in on ASPN. Canaccord Genuity Group dropped their price target on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research report on Friday, February 14th. Craig Hallum dropped their target price on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a report on Friday, February 14th. TD Cowen upgraded Aspen Aerogels to a "strong-buy" rating in a report on Tuesday, March 11th. Barclays lowered their price target on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating for the company in a research report on Wednesday, February 19th. Finally, B. Riley reduced their target price on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a research note on Wednesday, February 19th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Aspen Aerogels presently has an average rating of "Moderate Buy" and an average target price of $19.11.
View Our Latest Research Report on Aspen Aerogels
Aspen Aerogels Stock Up 0.4 %
ASPN stock traded up $0.02 during midday trading on Monday, hitting $5.57. The stock had a trading volume of 982,376 shares, compared to its average volume of 1,927,041. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The firm has a market cap of $457.32 million, a price-to-earnings ratio of 34.81 and a beta of 2.35. The business has a 50-day moving average of $6.54 and a two-hundred day moving average of $11.62. Aspen Aerogels, Inc. has a 52-week low of $4.80 and a 52-week high of $33.15.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, equities research analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.
Aspen Aerogels Company Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Recommended Stories

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.